Vitamin D supplementation had no obvious effect on attack duration or headache severity
MONDAY, Jan. 10, 2022 (HealthDay News) — Vitamin D supplementation could reduce headache attacks per month and headache days per month among migraine patients, according to a review published in the December issue of The American Journal of Emergency Medicine.
Chen Hu, from the Chongqing Hospital of Traditional Chinese Medicine in China, and colleagues conducted a systematic review of randomized controlled trials exploring the effect of vitamin D for migraine patients. Data were included for six randomized controlled trials with 301 patients.
The researchers found that vitamin D supplementation could reduce headache attacks per month, headache days per month, and migraine disability assessment questionnaire scores (mean differences, −2.74, −1.56, and −5.72, respectively) compared with controls, but it had no obvious effect on attack duration or headache severity.
“Our analysis is based on only six randomized controlled trials, and all of them have relatively small patient samples,” the authors write. “We need more randomized controlled trials with large patient [samples] to explore this issue.”
Abstract/Full Text (subscription or payment may be required)
Serum 25(OH)D May Serve as Biomarker of Disease Activity in IBD
Chronic Migraines More Common in Women With Enlarged Breast Tissue
Nutritional Deficiencies Seen in Youth Taking GLP-1 Receptor Agonists
Maternal Vitamin D Status Linked to Preterm Delivery
IBD Not Linked to Risk for Hypertensive Disorders of Pregnancy Overall
Mom"s Poor Sleep in Late Pregnancy Linked to Offspring"s Obesity Risk in Early Childhood
High Intake of Eggs, Peanuts in Pregnancy Does Not Lower Allergy Risk
Altered Markers of Ovarian Development Seen With Fetal Acetaminophen Exposure